-
Je něco špatně v tomto záznamu ?
Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta
SL. Collins, B. Alemdar, HJ. van Beekhuizen, C. Bertholdt, T. Braun, P. Calda, P. Delorme, JJ. Duvekot, L. Gronbeck, G. Kayem, J. Langhoff-Roos, L. Marcellin, P. Martinelli, O. Morel, M. Mhallem, M. Morlando, LN. Noergaard, A. Nonnenmacher, P....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, práce podpořená grantem
- MeSH
- císařský řez * MeSH
- delfská metoda MeSH
- gestační stáří MeSH
- hormony kůry nadledvin terapeutické užití MeSH
- hospitalizace MeSH
- hysterektomie * MeSH
- konzervativní terapie MeSH
- lidé MeSH
- management nemoci MeSH
- oxytocin terapeutické užití MeSH
- placenta accreta terapie MeSH
- polohování pacienta MeSH
- poporodní krvácení prevence a kontrola terapie MeSH
- pozorné vyčkávání MeSH
- stenty MeSH
- těhotenství MeSH
- ureter MeSH
- uterotonika terapeutické užití MeSH
- Check Tag
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- směrnice pro lékařskou praxi MeSH
The worldwide incidence of abnormally invasive placenta is rapidly rising, following the trend of increasing cesarean delivery. It is a heterogeneous condition and has a high maternal morbidity and mortality rate, presenting specific intrapartum challenges. Its rarity makes developing individual expertise difficult for the majority of clinicians. The International Society for Abnormally Invasive Placenta aims to improve clinicians' understanding and skills in managing this difficult condition. By pooling knowledge, experience, and expertise gained within a variety of different healthcare systems, the Society seeks to improve the outcomes for women with abnormally invasive placenta globally. The recommendations presented herewith were reached using a modified Delphi technique and are based on the best available evidence. The evidence base for each is presented using a formal grading system. The topics chosen address the most pertinent questions regarding intrapartum management of abnormally invasive placenta with respect to clinically relevant outcomes, including the following: definition of a center of excellence; requirement for antenatal hospitalization; antenatal optimization of hemoglobin; gestational age for delivery; antenatal corticosteroid administration; use of preoperative cystoscopy, ureteric stents, and prophylactic pelvic arterial balloon catheters; maternal position for surgery; type of skin incision; position of the uterine incision; use of interoperative ultrasound; prophylactic administration of oxytocin; optimal method for intraoperative diagnosis; use of expectant management; adjuvant therapies for expectant management; use of local surgical resection; type of hysterectomy; use of delayed hysterectomy; intraoperative measures to treat life-threatening hemorrhage; and fertility after conservative management.
Centre Hospitalier Régional Universitaire de Nancy Université de Lorraine France
Department of Gynaecological Oncology Erasmus Medical Center Rotterdam Netherlands
Department of Obstetrics and Gynecology CHR Citadelle University of Liege Liege Belgium
Department of Obstetrics and Gynecology Erasmus Medical Center Rotterdam Rotterdam Netherlands
Department of Obstetrics and Gynecology Hôpital Pellegrin CHU de Bordeaux Bordeaux France
Department of Obstetrics and Gynecology South General Hospital Stockholm Sweden
Department of Obstetrics Cliniques Universitaires Saint Luc Brussels Belgium
Department of Obstetrics Rigshospitalet University of Copenhagen Denmark
Department of Perinatology and Gynecology University of Medical Sciences Poznan Poland
Heinrich Heine University Düsseldorf Germany
Nuffield Department of Women's and Reproductive Health University of Oxford Oxford UK
Prenatal Zurich Zürich Switzerland
Sorbonne Paris Cité Université Paris Descartes Faculté de Médecine Paris France
The Fetal Medicine Unit John Radcliffe Hospital Oxford UK
Vivantes Network for Health Clinicum Neukoelln Clinic for Obstetric Medicine Berlin Germany
Vrouw and Baby University Medical Centre Utrecht Utrecht University Utrecht Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006543
- 003
- CZ-PrNML
- 005
- 20200521090303.0
- 007
- ta
- 008
- 200511s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ajog.2019.02.054 $2 doi
- 035 __
- $a (PubMed)30849356
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Collins, Sally L $u Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK; The Fetal Medicine Unit, John Radcliffe Hospital, Oxford, UK. Electronic address: sally.collins@wrh.ox.ac.uk.
- 245 10
- $a Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta / $c SL. Collins, B. Alemdar, HJ. van Beekhuizen, C. Bertholdt, T. Braun, P. Calda, P. Delorme, JJ. Duvekot, L. Gronbeck, G. Kayem, J. Langhoff-Roos, L. Marcellin, P. Martinelli, O. Morel, M. Mhallem, M. Morlando, LN. Noergaard, A. Nonnenmacher, P. Pateisky, P. Petit, MJ. Rijken, M. Ropacka-Lesiak, D. Schlembach, L. Sentilhes, V. Stefanovic, G. Strindfors, B. Tutschek, S. Vangen, A. Weichert, K. Weizsäcker, F. Chantraine, International Society for Abnormally Invasive Placenta (IS-AIP),
- 520 9_
- $a The worldwide incidence of abnormally invasive placenta is rapidly rising, following the trend of increasing cesarean delivery. It is a heterogeneous condition and has a high maternal morbidity and mortality rate, presenting specific intrapartum challenges. Its rarity makes developing individual expertise difficult for the majority of clinicians. The International Society for Abnormally Invasive Placenta aims to improve clinicians' understanding and skills in managing this difficult condition. By pooling knowledge, experience, and expertise gained within a variety of different healthcare systems, the Society seeks to improve the outcomes for women with abnormally invasive placenta globally. The recommendations presented herewith were reached using a modified Delphi technique and are based on the best available evidence. The evidence base for each is presented using a formal grading system. The topics chosen address the most pertinent questions regarding intrapartum management of abnormally invasive placenta with respect to clinically relevant outcomes, including the following: definition of a center of excellence; requirement for antenatal hospitalization; antenatal optimization of hemoglobin; gestational age for delivery; antenatal corticosteroid administration; use of preoperative cystoscopy, ureteric stents, and prophylactic pelvic arterial balloon catheters; maternal position for surgery; type of skin incision; position of the uterine incision; use of interoperative ultrasound; prophylactic administration of oxytocin; optimal method for intraoperative diagnosis; use of expectant management; adjuvant therapies for expectant management; use of local surgical resection; type of hysterectomy; use of delayed hysterectomy; intraoperative measures to treat life-threatening hemorrhage; and fertility after conservative management.
- 650 _2
- $a hormony kůry nadledvin $x terapeutické užití $7 D000305
- 650 12
- $a císařský řez $7 D002585
- 650 _2
- $a konzervativní terapie $7 D000072700
- 650 _2
- $a delfská metoda $7 D003697
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a gestační stáří $7 D005865
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hysterektomie $7 D007044
- 650 _2
- $a uterotonika $x terapeutické užití $7 D010120
- 650 _2
- $a oxytocin $x terapeutické užití $7 D010121
- 650 _2
- $a polohování pacienta $7 D056888
- 650 _2
- $a placenta accreta $x terapie $7 D010921
- 650 _2
- $a poporodní krvácení $x prevence a kontrola $x terapie $7 D006473
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a stenty $7 D015607
- 650 _2
- $a ureter $7 D014513
- 650 _2
- $a pozorné vyčkávání $7 D057832
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Alemdar, Bahrin $u Department of Obstetrics and Gynecology, South General Hospital, Stockholm, Sweden.
- 700 1_
- $a van Beekhuizen, Heleen J $u Department of Gynaecological Oncology, Erasmus Medical Center, Rotterdam, Netherlands.
- 700 1_
- $a Bertholdt, Charline $u Centre Hospitalier Régional Universitaire de Nancy, Université de Lorraine, France.
- 700 1_
- $a Braun, Thorsten $u Departments of Obstetrics and Division of Experimental Obstetrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
- 700 1_
- $a Calda, Pavel $u Department of Obstetrics and Gynecology, General Faculty Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Delorme, Pierre $u Port-Royal Maternity Unit, Cochin Hospital, Paris-Descartes University, DHU Risk and Pregnancy, Assistance Publique-Hôpitaux de Paris, Paris, France.
- 700 1_
- $a Duvekot, Johannes J $u Department of Obstetrics and Gynecology, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands.
- 700 1_
- $a Gronbeck, Lene $u Department of Obstetrics, Rigshospitalet, University of Copenhagen, Denmark.
- 700 1_
- $a Kayem, Gilles $u Department of Obstetrics and Gynecology, Hôpital Trousseau, Assistance Publique des Hôpitaux de Paris, Sorbonne University, Paris, France.
- 700 1_
- $a Langhoff-Roos, Jens $u Department of Obstetrics, Rigshospitalet, University of Copenhagen, Denmark.
- 700 1_
- $a Marcellin, Louis $u Department of Gynecology Obstetrics II and Reproductive Medicine, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, APHP; Sorbonne Paris Cité, Université Paris Descartes, Faculté de Médecine, Paris, France.
- 700 1_
- $a Martinelli, Pasquale $u Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.
- 700 1_
- $a Morel, Olivier $u Centre Hospitalier Régional Universitaire de Nancy, Université de Lorraine, France.
- 700 1_
- $a Mhallem, Mina $u Department of Obstetrics, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- 700 1_
- $a Morlando, Maddalena $u Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy; Department of Women, Children and of General and Specialized Surgery, University "Luigi Vanvitelli", Naples, Italy.
- 700 1_
- $a Noergaard, Lone N $u Department of Obstetrics, Rigshospitalet, University of Copenhagen, Denmark.
- 700 1_
- $a Nonnenmacher, Andreas $u Departments of Obstetrics and Division of Experimental Obstetrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
- 700 1_
- $a Pateisky, Petra $u Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Petit, Philippe $u Department of Obstetrics and Gynecology, CHR Citadelle, University of Liege, Liege, Belgium.
- 700 1_
- $a Rijken, Marcus J $u Vrouw & Baby, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands.
- 700 1_
- $a Ropacka-Lesiak, Mariola $u Department of Perinatology and Gynecology, University of Medical Sciences, Poznan, Poland.
- 700 1_
- $a Schlembach, Dietmar $u Vivantes Network for Health, Clinicum Neukoelln, Clinic for Obstetric Medicine, Berlin, Germany.
- 700 1_
- $a Sentilhes, Loïc $u Department of Obstetrics and Gynecology, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France.
- 700 1_
- $a Stefanovic, Vedran $u Department of Obstetrics and Gynecology, Fetomaternal Medical Center, Helsinki University Hospital and University of Helsinki, Finland.
- 700 1_
- $a Strindfors, Gita $u Department of Obstetrics and Gynecology, South General Hospital, Stockholm, Sweden.
- 700 1_
- $a Tutschek, Boris $u Prenatal Zurich, Zürich, Switzerland; Heinrich Heine University, Düsseldorf, Germany.
- 700 1_
- $a Vangen, Siri $u Division of Obstetrics and Gynaecology, Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Rikshospitalet and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- 700 1_
- $a Weichert, Alexander $u Departments of Obstetrics and Division of Experimental Obstetrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
- 700 1_
- $a Weizsäcker, Katharina $u Departments of Obstetrics and Division of Experimental Obstetrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
- 700 1_
- $a Chantraine, Frederic $u Department of Obstetrics and Gynecology, CHR Citadelle, University of Liege, Liege, Belgium.
- 710 2_
- $a International Society for Abnormally Invasive Placenta (IS-AIP)
- 773 0_
- $w MED00000270 $t American journal of obstetrics and gynecology $x 1097-6868 $g Roč. 220, č. 6 (2019), s. 511-526
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30849356 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200521090300 $b ABA008
- 999 __
- $a ok $b bmc $g 1525401 $s 1096599
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 220 $c 6 $d 511-526 $e 20190305 $i 1097-6868 $m American journal of obstetrics and gynecology $n Am J Obstet Gynecol $x MED00000270
- LZP __
- $a Pubmed-20200511
